Detailed Information on Publication Record
2020
Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
VERBRUGGEN, L. C., Y. H. WANG, S. H. ARMENIAN, M. J. EHRHARDT, H. J. H. VAN DER PAL et. al.Basic information
Original name
Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Authors
VERBRUGGEN, L. C. (528 Netherlands, guarantor), Y. H. WANG (528 Netherlands), S. H. ARMENIAN (840 United States of America), M. J. EHRHARDT (840 United States of America), H. J. H. VAN DER PAL (528 Netherlands), E. C. VAN DALEN (528 Netherlands), J. W. VAN AS (528 Netherlands), E . BARDI (40 Austria), K. BAUST (276 Germany), C. BERGER (250 France), E. CASTAGNOLA (380 Italy), K. A. DEVINE (840 United States of America), J . GEBAUER (276 Germany), J. G. MARCHAK (840 United States of America), A. W. GLASER (826 United Kingdom of Great Britain and Northern Ireland), A. H. GROLL (276 Germany), G. M. HAEUSLER (36 Australia), J. DEN HARTOGH (528 Netherlands), R. HAUPT (380 Italy), L. HJORTH (752 Sweden), M. KATO (392 Japan), Tomáš KEPÁK (203 Czech Republic, belonging to the institution), M. M. W. KOOPMAN (528 Netherlands), T. LANGER (276 Germany), M. MAEDA (392 Japan), G. MICHEL (756 Switzerland), M. MURACA (380 Italy), P. C. NATHAN (124 Canada), S. R. VAN DEN OEVER (528 Netherlands), V. PAVASOVIC (826 United Kingdom of Great Britain and Northern Ireland), S. SATO (392 Japan), F. SCHULTE (124 Canada), L. L. SUNG (124 Canada), W. TISSING (528 Netherlands), A. UYTTEBROECK (56 Belgium), R. L. MULDER (528 Netherlands), C. KUEHNI (756 Switzerland), R. SKINNER (826 United Kingdom of Great Britain and Northern Ireland), M. M. HUDSON (840 United States of America) and L. C. M. KREMER (528 Netherlands)
Edition
PEDIATRIC BLOOD & CANCER, HOBOKEN, WILEY, 2020, 1545-5009
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30209 Paediatrics
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.167
RIV identification code
RIV/00216224:14110/20:00116603
Organization unit
Faculty of Medicine
UT WoS
000572077700001
Keywords in English
childhood adolescent and young adult (CAYA) cancer survivors; COVID-19; late effects of cancer treatment
Tags
International impact, Reviewed
Změněno: 5/1/2021 13:30, Mgr. Tereza Miškechová
Abstract
V originále
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.